Table 3

Baseline chamber dimensions stratified by future outcomes

OutcomeLVIDdLVIDsLAD
Improved LVEF (n=30)54±642±748±9
Worsened/unchanged LVEF (n=22)58±846±950±8
P value0.020.070.53
No AF recurrence (n=26)56±744±747±7
AF recurrence56±843±951±10
P value0.700.670.14
Symptoms improved (n=33)55±643±747±7
Symptoms not improved (n=17)58±845±752±7
P value0.140.440.03
  • All measurements are expressed in millimetres.

  • AF, atrial fibrillation; LAD, left atrial diameter;LVEF, left ventricular ejection fraction;LVIDd, left ventricular internal diameter during end-diastole;LVIDs, left ventricular internal diameter during end-systole.